MC3R/MC4R — Compound Reference

Compound Reference Log · Deep Dive

MC3R/MC4R

MC3R and MC4R are two melanocortin receptors — cell-surface targets, not peptides — central to how melanocortin signaling influences energy balance.

Melanocortin receptorsG-protein-coupled receptorsTargets, not peptidesEnergy-balance signaling
Narrated · press play
01

What the name means

MC3R and MC4R stand for melanocortin receptor type 3 and type 4.

This is a receptor-class entry, not a single branded molecule. “Melanocortin” refers to the family of signaling peptides (such as alpha-MSH) that act at these receptors; the numbers distinguish the receptor subtypes. Reading the name literally: these are two members of the melanocortin receptor family.

02

What it actually is

MC3R and MC4R are proteins embedded in cell membranes — G-protein-coupled receptors — not short peptides that are dosed or injected.

CLASS: G-protein-coupled receptors (GPCRs)

ROLE: receive melanocortin peptide signals

TYPE: receptor targets, not administered substances

LIGANDS: melanocortin peptides (e.g. alpha-MSH) and synthetic agonists

Because these are receptors rather than chain-peptides, there is no amino-acid sequence to quote as a “compound.” The relevant concept is the agonist: a peptide that binds and switches the receptor on. Analogs such as melanocortin-agonist peptides are studied precisely because they act at these receptors.

03

Where it came from

The melanocortin receptors were identified as molecular biology mapped out the alpha-MSH signaling system.

As researchers cloned and characterized the receptors that respond to melanocortin peptides, distinct subtypes emerged, MC3R and MC4R among them. MC4R in particular became a major focus of energy-balance and body-weight research once genetics linked it to the regulation of appetite and metabolism.

04

Why it was created — the thought process

These receptors were not created — they are natural targets — but the agonist concept built around them is deliberate.

Understanding that MC3R and MC4R sit in pathways governing energy homeostasis made them attractive targets for research. The scientific idea is that a molecule which selectively activates the right receptor subtype could probe, or influence, that biology — which is why selective melanocortin agonists are an active area of study rather than a single finished product.

05

How it is made

This entry describes targets, so “how it is made” applies to the peptide agonists that act on them.

Melanocortin-agonist peptides are generally produced by solid-phase peptide synthesis, with cyclization and non-natural residues introduced where a design calls for greater stability or selectivity, followed by purification and mass-spectrometry confirmation. The receptors themselves are proteins expressed by cells in the body and, for laboratory study, in engineered cell lines.

06

What the research actually shows — honestly

Melanocortin-receptor biology is a legitimate and active research field, and this entry is a conceptual reference rather than a product page.

The role of MC3R and MC4R in energy balance is documented in peer-reviewed science, and selective agonists are an area of ongoing research. Nothing here is a use recommendation: the content is research-use-only, is not medical advice, and describes no protocol. Clinical questions belong with a qualified physician.

07

Selected research & sources

The items below are drawn from the peer-reviewed literature (PubMed) and describe results observed in research models or reported in the clinical literature. They are listed so the evidence can be examined at its source — not to suggest any use.

  1. van Santen HM, Denzer C, Müller HL. Front Endocrinol. 2024. “Could setmelanotide be the game-changer for acquired hypothalamic obesity?” doi.org/10.3389/fendo.2023.1307889
  2. Mayer D, Lynch SE. Ann Pharmacother. 2020. “Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.” doi.org/10.1177/1060028019899152

Regulatory status: Setmelanotide and bremelanotide are FDA-approved prescription drugs for their specific indications; RUO research material is not those drugs. Research material, RUO.

◆ A reference, not a recommendation

This page explains what MC3R/MC4R is and where it came from — the science and the story — not who should use anything, or how. These are research materials for laboratory research only; nothing here is medical, dosing, or treatment advice.

Explore furtherAll compounds · Reference LogThe Body & Peptide Science
Compound Reference Log · MC3R/MC4R
Research-use-only educational content. Factual overview; claims of clinical benefit are not implied.
For research use only — not for human consumption, and not for diagnosing, treating, curing, or preventing any disease or condition, or making any medical claim. BioBoost Research is an educational resource. Science and regulation are evolving, and the information here may be incomplete, become outdated, or contain errors. Nothing here is medical, legal, or dosing advice — always verify against primary sources and consult a qualified professional. All information reflects facts as best known to BioBoost Research. Full disclaimer →

On clinical data and dosing: Any clinical trials, data, or dosing figures referenced anywhere on this site were conducted in controlled settings under qualified professional and physician oversight, and are shown for informational and educational purposes only — never as guidance. BioBoost Research makes no claim that the same outcome or safety profile would apply to any compound, person, or context. Research and educational use only · 21+.

Read the full Disclaimer →